技术文章
- 2023/11/27Research Grade Parsatuzumab (DHJ76201)
- 2023/11/27Research Grade Eldelumab (DHC01901)
- 2023/11/27Research Grade Pavunalimab (DHD30408)
- 2023/11/27Research Grade Lenzilumab (DHC06703)
- 2023/11/27Research Grade Tinurilimab (DHE25601)
- 2023/11/27Research Grade Mupadolimab (DHD46604)
- 2023/11/27Research Grade Abituzumab (DHC21901)
- 2023/11/27Research Grade Natalizumab (DHC98801)
- 2023/11/27Research Grade Sotigalimab (DHD68911)
- 2023/11/27Research Grade Lucatumumab (DHD68905)
- 2023/11/27Research Grade Talquetamab (DHK07701)
- 2023/11/27Research Grade Cibisatamab (DHC21003)
- 2023/11/27Research Grade Burosumab (DHJ53401)
- 2023/11/27Research Grade Mirvetuximab (DHD10402)
- 2023/11/27Research Grade Naxitamab (DGK07803)
- 2023/11/27Research Grade Ponsegromab (DHJ48301)
- 2023/11/27Research Grade Glembatumumab (DHG93101)
